BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-α production through TGF-β-dependent and -independent mechanisms

Journal of Immunology

Volumn 168, Issue 11, 2002, Pages 5746-5755

  Finkel Jimenez, Beatriz ^a   Wüthrich, Marcel ^a   Klein, Bruce S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN BAD1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FUNGUS CULTURE; GENE LOCUS; IN VITRO STUDY; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS CELL INTERACTION;

EID: 0036604083     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.11.5746     Document Type: Article

References (36)

1. Mouse model of pulmonary blastomycosis: Utility, simplicity, and quantitative parameters
2. Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis
3. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis
4. The WI-I antigen on Blastomyces dermatitidis yeast mediates binding to human macrophage CD18 and CD14 receptors
5. Microbes, immunity, and disease: Type III secretion machines: Bacterial devices for protein delivery into host cells
6. Downregulation of phagocyte TNF-α production by the WI-1 adhesin imparts pathogenicity on Blastomyces dermatitidis
7. A simple method for the rapid generation of recombinant adenovirus vectors
8. Monoclonal antibodies recognizing TGF-β: Bioactivity neutralization and TGF-β2 affinity purification
9. Purification in quantity of the secreted form WI-1: A major adhesin on Blastomyces dermatitidis yeast
10. Cell wall biogenesis of Blastomyces dermatitidis
11. Alteration of polymorphonuclear leukocytes activity by viable Candida albicans
12. Assay for transforming growth factor β
13. Mechanisms generating functionally heterogeneous macrophages: Chaos revisited
14. Regulation of immune responses by TGF-β
15. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor β and interleukin-10
16. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins
17. Altered expression of the surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeast by human macrophages
18. Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans
19. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms
20. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ
21. Tumor necrosis factor is required in the protective immune response against Mycobacterium tuberculosis in mice
22. Transforming growth factor-β in leishmanial infection: A parasite escape mechanism
23. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis
24. The importance of TGF-β in murine visceral leishmaniasis
25. TGF-β mediates CTLA-4 suppression of cellular immunity in murine kalaazar
26. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β)
27. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages
28. Cross-modulation by transforming growth factor β in human tuberculosis: Suppression of antigen-drive blastogenesis and interferon γ production
29. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β
30. Cryptococcus neoformans
31. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages
32. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils
33. Cryptococcal polysaccharides bind to CD18 on human neutrophils
34. Toll-like receptor 4 mediates intracellular signaling without TNF release in response to Cryptococcus neoformans polysaccharide capsule